Immune Tolerance Network (UM1 Clinical Trial Required)
Key Details
Context & Analysis
National Institutes of Health posted this funding opportunity on October 20, 2026 (opportunity number RFA-AI-28-005). It is catalogued under CFDA number 93.855. Applications are accepted through January 29, 2027 — 94 days remaining.
Similar Grant Opportunities
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
National Institutes of Health
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
National Institutes of Health
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
National Institutes of Health
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
National Institutes of Health
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
National Institutes of Health
Stay Updated
Get notified about new opportunities matching your interests.